The 8th Annual DTx West conference, now under the ownership of Cambridge Healthtech Institute, is set to take place at the Town and Country Resort in San Diego, CA on March 13-14, 2025. This year, the conference relaunches as part of the new DTx Global Summit brand, promising to be the largest event in its history.
The DTx Series, since its inception in 2017, has been the pivotal meeting point for professionals focused on advancing validated digital healthcare. With the industry's evolution, the series continues to unite leaders from healthcare, pharma, biotech, and academia to accelerate the next generation of digital health solutions reaching patients in need.
Notable participants from past events include Aetna, Amazon, Google, Eli Lilly, Pfizer, and Mayo Clinic, underscoring the conference's credibility and industry-wide support. This year's conference will draw a diverse audience of digital therapeutics professionals, offering insights into reimbursement, investment, pharmaceutical partnerships, evidence standards, the payer perspective, and AI in healthcare.
Chris Wasden, Senior Vice President at Dario Health, stated, "I have attended the DTx West and East events since their inception. I have found that these events are more focused on the challenges, needs, successes, and opportunities for the digital health industry than any other industry events. It brings together digital health technology companies, health payers, pharmaceutical companies, healthcare providers, and other service providers that are helping to move the industry forward."
Attendees can expect a blend of practical insights, networking opportunities, and cutting-edge presentations, further solidifying the DTx Global Summit's reputation as a critical platform for innovation in digital health.
The final agenda is available online at www.dtxglobalsummit.com/west.
The DTx Series, since its inception in 2017, has been the pivotal meeting point for professionals focused on advancing validated digital healthcare. With the industry's evolution, the series continues to unite leaders from healthcare, pharma, biotech, and academia to accelerate the next generation of digital health solutions reaching patients in need.
Notable participants from past events include Aetna, Amazon, Google, Eli Lilly, Pfizer, and Mayo Clinic, underscoring the conference's credibility and industry-wide support. This year's conference will draw a diverse audience of digital therapeutics professionals, offering insights into reimbursement, investment, pharmaceutical partnerships, evidence standards, the payer perspective, and AI in healthcare.
Chris Wasden, Senior Vice President at Dario Health, stated, "I have attended the DTx West and East events since their inception. I have found that these events are more focused on the challenges, needs, successes, and opportunities for the digital health industry than any other industry events. It brings together digital health technology companies, health payers, pharmaceutical companies, healthcare providers, and other service providers that are helping to move the industry forward."
Attendees can expect a blend of practical insights, networking opportunities, and cutting-edge presentations, further solidifying the DTx Global Summit's reputation as a critical platform for innovation in digital health.
The final agenda is available online at www.dtxglobalsummit.com/west.
